Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
about
Therapeutic strategies against cancer stem cells in human colorectal cancer.Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells.A20 regulates canonical wnt-signaling through an interaction with RIPK4.Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway.Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma.
P2860
Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@en
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@nl
type
label
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@en
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@nl
prefLabel
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@en
Targeting RAS signaling pathwa ...... reatment of colorectal cancer.
@nl
P2093
P2860
P50
P356
P1476
Targeting RAS signaling pathwa ...... treatment of colorectal cancer
@en
P2093
Afsane Bahrami
Amir Aledavood
Gordon A Ferns
Majid Khazaei
Malihe Hasanzadeh
Mina Maftouh
Soodabeh ShahidSales
Zahra Farjami
P2860
P304
P356
10.1002/JCP.25890
P577
2017-05-23T00:00:00Z